Company record · GCAN · Pharmaceutical Preparations
The Greater Cannabis Company, Inc.
The Greater Cannabis Company, Inc.'s chief financial officer on the record is Michelle Cervantes Vivanco, effective July 29, 2026, per the filing record.
The record holds 1 verified CFO change for The Greater Cannabis Company, Inc. from Form 8-K filings, filed July 31, 2026 and the CFO signature on its 10-K filed March 31, 2026.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Filled |
|---|---|
| Officer | Michelle Cervantes Vivanco |
| Title as printed | Chief Financial Officer |
| Basis | Latest move: appointment, 8-K filed July 31, 2026 |
Seat timeline
2Every verified record for this seat, newest first, dated as the filing states it.
2026-07-31Appointment
The Greater Cannabis Company, Inc. appoints Michelle Cervantes Vivanco as CFOeffective July 29, 2026 · 8-K filed July 31, 2026 · sec.gov, Item 5.02
2026-03-3110-K signature
Aitan Zacharin signed the annual report as President (Principal Executive Officer), Acting Chief Financial Officer (Principal Accounting Officer) and Chairman of the Board of Directors
10-K filed March 31, 2026 · sec.gov
“/s/ Aitan Zacharin President (Principal Executive Officer), Acting Chief Financial Officer March 31, 2026 (Principal Accounting Officer) and Chairman of the Board of Directors”
Company
| Ticker | GCAN |
|---|---|
| SEC CIK | 0001695473 |
| Industry (SIC) | Pharmaceutical Preparations (2834) |
| Roster note | No DEF 14A in the recent filings to cross-check. An 8-K with Item 5.02 was filed on 2026-09-21, after this 10-K; any CFO change it reports is tracked on the moves record. |
Same industry on the record
8Other companies the roster files under SIC “Pharmaceutical Preparations”.
Cadrenal Therapeutics, Inc.CVKD
Interim CFO: John P. Sharp · effective June 25, 2026
Petros Pharmaceuticals, Inc.PTPI
Departure disclosed · Robert Weinstein · no successor on the record yet
Actinium Pharmaceuticals, Inc.ATNM
CFO: Matt David, M.D. · effective October 14, 2026
Adial Pharmaceuticals, Inc.ADIL
Departure disclosed · Vinay Shah · no successor on the record yet
BeyondSpring Inc.BYSI
CFO: Na Li · effective July 1, 2026
CalciMedica, Inc.CALC
Departure disclosed · Stephen Bardin · no successor on the record yet
Cue Biopharma, Inc.CUE
CFO: James Ahlers · effective July 30, 2026
Emergent BioSolutions Inc.EBS
Change disclosed, effective January 1, 2027 · incoming: Frank Vargo
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.